To validate in a second independent model that p53EE enhances the chemotherapy response in vivo, we transplanted syngeneic recipient mice with AE9/Nras‐driven acute myeloid leukemia cells with different p53 genotypes and monitored disease progression by bioluminescence imaging (Fig 7G). This evidence concerns the gene TP53 and acute myeloid leukemia.